Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation
Tài liệu tham khảo
Asai, 2001, Regulation of mast cell survival by IgE, Immunity, 14, 791, 10.1016/S1074-7613(01)00157-1
Bonnerot, 1992, Role of associated γ-chain in tyrosine kinase activation via murine FcγRIII, EMBO J., 11, 2747, 10.1002/j.1460-2075.1992.tb05340.x
Coggeshall, 2002, How do inhibitory phosphatases work?, Mol. Immunol., 39, 521, 10.1016/S0161-5890(02)00209-2
Davis, 2002, Fc receptor homologs, Immunol. Rev., 190, 123, 10.1034/j.1600-065X.2002.19009.x
Dittel, 1999, Cross-antagonism of a T cell clone expressing two distinct T cell receptors, Immunity, 11, 289, 10.1016/S1074-7613(00)80104-1
Ganesan, 2003, The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of FcγRIIa to modulate signaling events in myeloid cells, J. Biol. Chem., 278, 35710, 10.1074/jbc.M305078200
Gulle, 1998, Physical and functional association of FcαR with protein tyrosine kinase Lyn, Blood, 91, 383, 10.1182/blood.V91.2.383
Herr, 2003, Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc, Nature, 423, 614, 10.1038/nature01685
Kalesnikoff, 2001, Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival, Immunity, 14, 801, 10.1016/S1074-7613(01)00159-5
Kerr, 1990, The structure and function of human IgA, Biochem. J., 271, 285, 10.1042/bj2710285
Kimura, 1997, Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor, J. Immunol., 159, 4426, 10.4049/jimmunol.159.9.4426
Kinet, 1999, The high-affinity IgE receptor (FcϵRI), Annu. Rev. Immunol., 17, 931, 10.1146/annurev.immunol.17.1.931
Kitaura, 2003, Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcϵRI, Proc. Natl. Acad. Sci. USA, 100, 12911, 10.1073/pnas.1735525100
Launay, 1998, IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways, J. Leukoc. Biol., 63, 636, 10.1002/jlb.63.5.636
Launay, 1999, Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRγ association and protects against degradation of bound ligand, J. Biol. Chem., 274, 7216, 10.1074/jbc.274.11.7216
Launay, 2000, Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice, J. Exp. Med., 191, 1999, 10.1084/jem.191.11.1999
Liu, 1980, Monoclonal dinitrophenyl-specific murine IgE antibody, J. Immunol., 124, 2728, 10.4049/jimmunol.124.6.2728
Long, 1999, Regulation of immune responses through inhibitory receptors, Annu. Rev. Immunol., 17, 875, 10.1146/annurev.immunol.17.1.875
Marchand, 2003, Human serum IgE-mediated mast cell degranulation shows poor correlation to allergen-specific IgE content, Allergy, 58, 1037, 10.1034/j.1398-9995.2003.00251.x
Monteiro, 2003, IgA Fc receptors, Annu. Rev. Immunol., 21, 177, 10.1146/annurev.immunol.21.120601.141011
Monteiro, 1990, Cellular distribution, regulation, and biochemical nature of an Fcα receptor in humans, J. Exp. Med., 171, 597, 10.1084/jem.171.3.597
Monteiro, 1992, Molecular heterogeneity of Fc alpha receptors detected by receptor-specific monoclonal antibodies, J. Immunol., 148, 1764, 10.4049/jimmunol.148.6.1764
Monteiro, 1993, Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals, J. Clin. Invest., 92, 1681, 10.1172/JCI116754
Morton, 1995, Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcRγ chain, Molecular basis for CD, 89, 29781
Morton, 1999, Immunoglobulin-binding sites of human FcαRI (CD89) and bovine Fcγ2R are located in their membrane-distal extracellular domains, J. Exp. Med., 189, 1715, 10.1084/jem.189.11.1715
Nakamura, 2002, The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcγ receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors, Blood, 100, 3374, 10.1182/blood-2002-03-0787
Nikolova, 1995, Dual function of human IgA antibodies, J. Leukoc. Biol., 57, 875, 10.1002/jlb.57.6.875
Park, 1999, Role of Src in the modulation of multiple adaptor proteins in FcαRI oxidant signaling, Blood, 94, 2112, 10.1182/blood.V94.6.2112
Pastorelli, 2001, IgE receptor type I-dependent tyrosine phosphorylation of phospholipid scramblase, J. Biol. Chem., 276, 20407, 10.1074/jbc.M100790200
Phalipon, 2003, Novel functions of the polymeric Ig receptor, Trends Immunol., 24, 55, 10.1016/S1471-4906(02)00031-5
Ravetch, 2001, IgG Fc receptors, Annu. Rev. Immunol., 19, 275, 10.1146/annurev.immunol.19.1.275
Roa, 1997, Involvement of the ras-like GTPase rab3d in RBL-2H3 mast cell exocytosis following stimulation via high affinity IgE receptors (FcϵRI), J. Immunol., 159, 2815, 10.4049/jimmunol.159.6.2815
Russell, 1997, IgA antibody as a non-inflammatory regulator of immunity, Biochem. Soc. Trans., 25, 466, 10.1042/bst0250466
Schaffer, 1991, IgA deficiency, Immunodefic. Rev., 3, 15
Schuppel, 1987, Monoclonal anti-allotype antibody towards BALB/c IgM. Analysis of specificity and site of a V–C crossover in recombinant strain BALB-Igh-Va/Igh-Cb, Eur. J. Immunol., 17, 739, 10.1002/eji.1830170527
Shen, 1989, My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function, J. Immunol., 143, 4117, 10.4049/jimmunol.143.12.4117
Shen, 2001, Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor γ-chain signaling, Blood, 97, 205, 10.1182/blood.V97.1.205
Silvain, 1995, Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-γ, J. Immunol., 155, 1606, 10.4049/jimmunol.155.3.1606
Stefanova, 2003, TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways, Nat. Immunol., 4, 248, 10.1038/ni895
Torigoe, 1998, An unusual mechanism for ligand antagonism, Science, 281, 568, 10.1126/science.281.5376.568
Unkeless, 1979, Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors, J. Exp. Med., 150, 580, 10.1084/jem.150.3.580
van Egmond, 2001, IgA and the IgA Fc receptor, Trends Immunol., 22, 205, 10.1016/S1471-4906(01)01873-7
Van Epps, 1976, Suppression of leukocyte chemotaxis by human IgA myeloma components, J. Exp. Med., 144, 1227, 10.1084/jem.144.5.1227
Van Epps, 1981, Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins, Infect. Immun., 34, 864, 10.1128/iai.34.3.864-870.1981
Van Epps, 1978, Suppression of human PMN bactericidal activity by human IgA paraproteins, Cell. Immunol., 36, 363, 10.1016/0008-8749(78)90280-0
Wilton, 1978, Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes, Clin. Exp. Immunol., 34, 423
Wines, 2001, The interaction of FcαRI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster, J. Immunol., 166, 1781, 10.4049/jimmunol.166.3.1781
Wolf, 1994, Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-α, interleukin-6) in human monocytes, Blood, 83, 1278, 10.1182/blood.V83.5.1278.1278
Wolf, 1996, Anti-inflammatory properties of human serum IgA, Clin. Exp. Immunol., 105, 537, 10.1046/j.1365-2249.1996.d01-793.x
Xu, 1999, Cutting edge, J. Immunol., 163, 1110, 10.4049/jimmunol.163.3.1110
Zhang, 1997, Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells, Indications of communication between p, 38, 13397
Zuany-Amorim, 1998, Requirement for gammadelta T cells in allergic airway inflammation, Science, 280, 1265, 10.1126/science.280.5367.1265
Zuberi, 2000, Role for IgE in airway secretions, J. Immunol., 164, 2667, 10.4049/jimmunol.164.5.2667